ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
911ST
|
2.7K |
1.0M |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
911ST
|
2.7K |
1.0M |
3 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
911ST
|
2.7K |
1.0M |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: CHDR to conduct first-in-human phase 1 trial of IMP761
|
|
911ST
|
10 |
4.2K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
10
|
4.2K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
911ST
|
743 |
331K |
0 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
743
|
331K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
911ST
|
743 |
331K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
743
|
331K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
911ST
|
743 |
331K |
18 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
743
|
331K
|
18
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
911ST
|
48 |
14K |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
48
|
14K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
911ST
|
2.7K |
1.0M |
9 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
911ST
|
670 |
251K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
670
|
251K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Future Announcements
|
|
911ST
|
37 |
7.0K |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
37
|
7.0K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Future Announcements
|
|
911ST
|
37 |
7.0K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
37
|
7.0K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Future Announcements
|
|
911ST
|
37 |
7.0K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
37
|
7.0K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Future Announcements
|
|
911ST
|
37 |
7.0K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
37
|
7.0K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
911ST
|
2.7K |
1.0M |
6 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
911ST
|
2.7K |
1.0M |
18 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
2.7K
|
1.0M
|
18
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Corporate Presentation - March 2024
|
|
911ST
|
40 |
15K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
40
|
15K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
911ST
|
56 |
30K |
2 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
56
|
30K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
911ST
|
56 |
30K |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
56
|
30K
|
1
|
|